Virtual Education Showcase

Placeholder search and filter

ipsum

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Note: Click the arrow in the bottom right of video to show fullscreen option.

Showing 0 results

Interventional EUS: The World Beyond WON - Part 2 Approach to Gastric Outlet & Duodenal Obstruction: Benign & Malignant - Pyloric, Duodenal Stents & EUS G-J

May 14, 2024

FITE

Moderated by Dr. Neil Sharma, part two of Interventional EUS: The World Beyond WON includes a presentation on gastric outlet and duodenal obstruction by Drs. Reem Sharaiha, Yen Chen, and Mouen Khashab. Topics include a look at data, procedural techniques, the learning curve, patient selection, and complication management.

Assessing the Myotomy During POEM

May 8, 2024

AFS

Medtronic

Moderated by Dr. Mike Ujiki, Drs. Andrew Sean Kastenmeier and Zachary Callahan discuss myotomy during POEM. The panelists inform on methods, techniques, and successful determination of myotomy. They explore advanced imaging modalities and intraoperative tools that can assist in assessing the completeness of myotomy during a POEM, as well as workup and treatment of dysphagia after a POEM.

Interventional EUS: The World Beyond WON – Part-1 A Brave New World: EUS Ostomy of the Gallbladder

May 1, 2024

FITE

Moderated by Dr. Neil Sharma, Drs. Lindsay Riegle, Shyam Varadarajulu and Anand Sahai kick off the Interventional EUS: The World Beyond Won three part webinar series. The panelists discuss data, patient selection, the learning curve, adverse events, and outcomes of EUS ostomy of the gallbladder through a multidisciplinary approach.

FITE 1k-10k, VirtualEd 10-100, interventional 1k-10k, therapeutic 10k-100k, interventional endoscopy 100-1k, therapeutic endoscopy 100-1k, WON 10k-100k, interventional EUS 10-100, interventional endoscopic ultrasound 10-100, endoscopic ultrasound 10k-100k, EUS 10k-100k, walled-off necrosis 100-1k, walled off necrosis 100k-1m, necrosis, gallbladder 100k-1m, necrotizing gallbladder 10-100, gallbladder necrosis 100-1k, cholecystitis 100k-1m, necrotizing cholecystitis 100-1k, gallstones 100k-1m, cholelithiasis 10k-100k, surgical endoscopy 100-1k, cholecystectomy 100k-1m, EUS-GDB, drainage 10k-100k, eus guided drainage 10-100, acute cholelithiasis 100-1k, Neil Sharma 100-1k, Shyam Varadarajulu 10-100, Anand Sahai 10-100, Lindsay Reigle 10k-100k, Replay 10k-100k, Dr. Sharma, Dr Sharma 10k-100k, Dr. Varadarajulu, Dr Varadarajulu 100-1k, Dr. Sahai, Dr Sahai 100-1k, Dr. Reigle 100-1k, Dr Reigler 100-1k, learning curve 10k-100k

Masters in Endoscopy Part-1: Current Gaps and Risk Stratification in Barrett's Esophagus

April 10, 2024

Castle Biosciences

In part one of four in the Masters in Endoscopy series, Dr. Srinadh Komanduri examines current challenges with the current screening and surveillance paradigm in Barrett’s esophagus treatment. Dr. Komanduri discusses the need to increase the denominator and tools for risk-stratification. Learn the ideas and implementation of molecular testing to identify non-dysplastic patients’ personal risk of HGD/EAC.

The Impact of GLP1RA: Considerations for GI Physicians & Surgeons

March 20, 2024

AFS

Drs. Mike Ujiki, Carolyn Newberry, Manoel Galvao Neto, and Anthony Starpoli review GLP1RA. The panelists identify the current FDA-approved formulations on the market in the US and abroad. They define the current perioperative procedures regarding GLP1RAs in patients undergoing endoscopic or surgical procedures. Listen to the discussion on the current clinical practice in adding GLP1RAs to endoscopic bariatric procedures.

AFS, american foregut society, virtualed, glp1ra, glucagon-like peptide-1 receptor agonists, peptide1, glucagonlike, agonists, diabetes, obesity, dmii, dm2, diabetes mellitus, diabetes mellitus type 2, type 2, type2, weight, weight loss, weight management, weight loss medication, bmi, overweight, ozempic, wegovy, bariatrics, bariatric endoscopy, bariatric, GLP-1, GLP1, surgical endoscopy, gastroenterology, weight loss drug, weight loss drugs, glucagon, EBT, endoscopic bariatric therapy, Dr Ujiki, Dr. Ujiki, Dr. Mike Ujiki, Dr Mike Ujiki, Dr. Newberry, Dr Newberry, Dr. Carolyn Newberry, Dr Carolyn Newberry, Dr. Neto, Dr Neto, Dr. Manoel Galvao Neto, Dr Manoel Galvao Neto, Dr. Starpoli, Dr Starpoli, Dr. Anthony Starpoli, Dr Anthony Starpoli

Incorporating Single-Use Duodenoscopes into your Practice

March 19, 2024

Boston Scientific EDUCARE

Dr. Sumit Singla and Ann Roy (Vice President, Health Economics and Market Access) of Boston Scientific analyze the use and implementation of single-use duodenoscopes in your practice. They explore the rationale and benefits of single-use duodenoscopes, as well as the economic implications of their use. See the clinical performance of the Exalt Model D single-use duodenoscope.

boston scientific, bsc, boston, ERCP, single-use, single use, duodenoscope. single-use duodenoscope, single use duodenoscope, single use scope, single-use scope, bile duct, biliary, biliary stricture, bile duct stone, stone, stones, choledocholithiasis, cholecystitis, stricture, pancreas, pancreatic duct, pancreas duct, exalt, exalt model d, cholangiocarcinoma, pancreatic cancer, pancreas cancer, cannulation, infection, pancreas stricture, pancreatic stricture, rfa, radiofrequency ablation, ampulla, ampullary, Ann Roy, Dr. Singla, Dr Singla, Dr Sumit Singla, Dr. Sumit Singla, Sumit Singla